Background macular Shape Background macular Shape Background macular Shape
Grants > Chlamydia Pneumonia Infection and Incidence of Age-Related Macular Degeneration Updated On: Jan. 21, 2025
Macular Degeneration Research Grant

Chlamydia Pneumonia Infection and Incidence of Age-Related Macular Degeneration

a headshot of Luba Robman, MBBS, PhD

Principal Investigator

Luba Robman, MBBS, PhD

Centre for Eye Research Australia (Australia)

Melbourne, Australia

About the Research Project

Program

Macular Degeneration Research

Award Type

Standard

Award Amount

$50,000

Active Dates

April 01, 2005 - March 31, 2006

Grant ID

M2005012

Summary

Recent studies have indicated an inflammatory component in the development of age-related macular degeneration (AMD). It is biologically plausible that such an inflammation is either caused by or aggravated in the presence of chronic infection. Two cross-sectional studies have demonstrated the prevalence of antibodies to Chlamydia pneumonia elementary bodies to be significantly higher in subjects with AMD compared to age-matched controls. Dr. Robman believes that Chlamydia pneumonia infection may play a causal role in the development of AMD and, therefore, aims to test an association between exposure to the Chlamydia pneumonia infection and the incidence of early AMD. If the causative link between Chlamydia pneumonia infection and the development of AMD is confirmed, long-term clinical trials of antibiotic therapy will be necessary to confirm or refute a pathogenic role for these organisms.